Vitae Pharmaceuticals Proposes Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
Vitae Pharmaceuticals (VTAE) Sees 'Substantial' Costs for Developing VTP-43742, VTP-38543, VTP-36951
March 23, 2016 4:18 PM EDTVitae Pharmaceuticals (NASDAQ: VTAE) disclosed he following on Wednesday night:
ITEM 7.01. REGULATION FD DISCLOSURE.
On March 23, 2016, Vitae Pharmaceuticals, Inc. (Vitae) announced that Vitae currently anticipates that the net proceeds from the proposed public offering of its common stock,... More
